These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 926240)

  • 1. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
    Fosså SD; Fosså J; Aakvaag A
    J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma hormone levels in patients with prostatic carcinoma treated with diethylstilboestrol and estramustine.
    Bishop MC; Selby C; Taylor M
    Br J Urol; 1985 Oct; 57(5):542-7. PubMed ID: 3904908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP; Wajsman Z; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of prostatic carcinoma with various types of estrogen derivatives.
    Jönsson G; Olsson AM; Luttrop W; Cekan Z; Purvis K; Diczfalusy E
    Vitam Horm; 1975; 33():351-76. PubMed ID: 1229063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal effects of different doses of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Fritjofsson A; Norlén BJ; Högberg B; Rajalakshmi M; Cekan SZ; Diczfalusy E
    Scand J Urol Nephrol; 1981; 15(1):37-44. PubMed ID: 6787701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA; Rosenthal H; Mittelman A; Murphy GP
    Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of advanced carcinoma of the prostate with estramustine phosphate.
    Fosså SD; Miller A
    J Urol; 1976 Apr; 115(4):406-8. PubMed ID: 1263316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of cyproterone acetate and estramustine phosphate on the plasma levels of testosterone and gonadotrophic hormones in adenocarcinoma of the prostate].
    Alfonso Sánchez M; Pérez Herrero F; Urrutia Avisrror M; Vega Wong J; Lago Montero A
    Actas Urol Esp; 1986; 10(2):111-6. PubMed ID: 2942009
    [No Abstract]   [Full Text] [Related]  

  • 9. The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.
    Daehlin L; Damber JE; von Schoultz B; Bergman B
    Br J Urol; 1986 Aug; 58(4):412-6. PubMed ID: 3092893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of estramustine phosphate on plasma testosterone during treatment of carcinoma of prostate.
    Kjaer TB; Nilsson T; Madsen PO
    Urology; 1975 Jun; 5(6):802-4. PubMed ID: 1136096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estramustine phosphate therapy in carcinoma of the prostate.
    Andersson L; Edsmyr F; Jönsson G; Könyves I
    Recent Results Cancer Res; 1977; (60):73-7. PubMed ID: 866798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD; Rozencweig M; Slavik M; Muggia FM
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinoma.
    Edsmyr F; Esposti PL; Johansson B; Strindberg B
    J Urol; 1978 Dec; 120(6):705-7. PubMed ID: 731810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study.
    Andersson L; Berlin T; Boman J; Collste L; Edsmyr F; Esposti PL; Gustafsson H; Hedlund PO; Hultgren L; Leander G; Nordle O; Norlén H; Tillegård P
    Scand J Urol Nephrol Suppl; 1980; 55():143-5. PubMed ID: 6259722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estramustine phosphate in the treatment of advanced prostatic cancer.
    Küss R; Khoury S; Richard F; Fourcade F; Frantz P; Capelle JP
    Br J Urol; 1980 Feb; 52(1):29-33. PubMed ID: 7426949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of stage D hormone-resistant carcinoma of the prostate with estramustine phosphate.
    Benson RC; Wear JB; Gill GM
    J Urol; 1979 Apr; 121(4):452-4. PubMed ID: 439216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD; O'Donoghue EP; Kennedy CL
    Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of advanced carcinoma of the prostate with Estracyt (author's transl)].
    Nagel R; Kölln CP
    Med Klin; 1976 Oct; 71(41):1724-8. PubMed ID: 824540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.